Gabriele Meloni

Prof. Gabriele Meloni

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2011 in JBIC Journal of Biological Inorganic Chemistry
Verified
Journal Article
Closed access
PDF file
MVMilan Vašák
Milan Vašák
GMGabriele Meloni
Gabriele Meloni

4 May 2008 in Nature Chemical Biology
Verified
Journal Article
Closed access
GMGabriele Meloni
Gabriele Meloni
VSVanessa Sonois
Vanessa Sonois
TDTamara Delaine
Tamara Delaine
LGLuc Guilloreau
Luc Guilloreau
AGAudrey Gillet
Audrey Gillet
MVMilan Vašák
Milan Vašák

13 March 2017 in IUBMB Life
Verified
Journal Article
Closed access
PDF file
JCJenifer Calvo
Jenifer Calvo
HJHUNMIN JUNG
HUNMIN JUNG
GMGabriele Meloni
Gabriele Meloni

17 August 2014 in Nature
Verified
Journal Article
Closed access
PDF file
KWKaituo Wang
Kaituo Wang
OSOleg Sitsel
Oleg Sitsel
GMGabriele Meloni
Gabriele Meloni
HAHenriette Elisabeth Autzen
Henriette Elisabeth Autzen
MAMagnus Andersson
Magnus Andersson
PGPontus Gourdon
Pontus Gourdon

1 June 2007 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
GMGabriele Meloni
Gabriele Meloni
Peter FallerPeter Faller
Peter Faller
MVMilan Vaša´k
Milan Vaša´k
Dysregulation of copper and zinc homeostasis in the brain plays a critical role in Alzheimer disease (AD). Copper binding to amyloid-β peptide (Aβ) is linked with the neurotoxicity of Aβ and free radical damage. Metallothionein-3 (MT-3) is a small cysteine- and metal-rich protein expressed in the brain and found down-regulated in AD. This protein occurs intra- and extracellularly, and it plays an important role in the metabolism of zinc and copper. In cell cultures Zn7MT-3, by an unknown mechanism, protects neurons from the toxicity of Aβ. We have, therefore, used a range of complementary spectroscopic and biochemical methods to characterize the interaction of Zn7MT-3 with free Cu2+ ions. We show that Zn7MT-3 scavenges free Cu2+ ions through their reduction to Cu+ and binding to the protein. In this reaction thiolate ligands are oxidized to disulfides concomitant with Zn2+ release. The binding of the first four Cu2+ is cooperative forming a Cu(I)4-thiolate cluster in the N-terminal domain of Cu4,Zn4MT-3 together with two disulfides bonds. The Cu4-thiolate cluster exhibits an unusual stability toward air oxygen. The results of UV-visible, CD, and Cu(I) phosphorescence at 77 K suggest the existence of metal-metal interactions in this cluster. We have demonstrated that Zn7MT-3 in the presence of ascorbate completely quenches the copper-catalyzed hydroxyl radical (OH·) production. Thus, zinc-thiolate clusters in Zn7MT-3 can efficiently silence the redox-active free Cu2+ ions. The biological implication of our studies as to the protective role of Zn7MT-3 from the Cu2+ toxicity in AD and other neurodegenerative disorders is discussed.

Verified
Journal Article
Open access
PDF file
MVMilan Vašák
Milan Vašák
GMGabriele Meloni
Gabriele Meloni
Metallothionein-3 (MT-3), a member of the mammalian metallothionein (MT) family, is mainly expressed in the central nervous system (CNS). MT-3 possesses a unique neuronal growth inhibitory activity, and the levels of this intra- and extracellularly occurring metalloprotein are markedly diminished in the brain of patients affected by a number of metal-linked neurodegenerative disorders, including Alzheimer’s disease (AD). In these pathologies, the redox cycling of copper, accompanied by the production of reactive oxygen species (ROS), plays a key role in the neuronal toxicity. Although MT-3 shares the metal-thiolate clusters with the well-characterized MT-1 and MT-2, it shows distinct biological, structural and chemical properties. Owing to its anti-oxidant properties and modulator function not only for Zn, but also for Cu in the extra- and intracellular space, MT-3, but not MT-1/MT-2, protects neuronal cells from the toxicity of various Cu(II)-bound amyloids. In recent years, the roles of zinc dynamics and MT-3 function in neurodegeneration are slowly emerging. This short review focuses on the recent developments regarding the chemistry and biology of MT-3.